rxstat › Classes › Antiarrhythmics, Class I And Iii

Antiarrhythmics, Class I And Iii: shortage status in Canada

3 of the 8 antiarrhythmics, class i and iii rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Procainamide (Procan) Widespread shortage 4 of 5 reported products affected Flecainide Partial shortage 2 of 8 reported products affected · est. return Apr 30, 2027 Lidocaine (Xylocaine) Partial shortage 2 of 24 reported products affected Amiodarone No current shortage Bretylium Tosylate Discontinued 0 of 1 reported products affected Disopyramide (Rythmodan) Discontinued 0 of 1 reported products affected Mexiletine No current shortage Propafenone (Rythmol) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.